Orteronel (TAK-700)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Orteronel (TAK-700), covering 2018-03-05 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer [Phase 3]